Treatment of Cellulitis of the Ear
Recommended Antibiotic Therapy
For cellulitis of the ear, treat with oral beta-lactam monotherapy such as cephalexin 500 mg four times daily, dicloxacillin 250-500 mg every 6 hours, or amoxicillin for 5 days, extending only if symptoms have not improved within this timeframe. 1
First-Line Treatment Selection
- Beta-lactam monotherapy is the standard of care for typical uncomplicated cellulitis, with a 96% success rate, confirming that MRSA coverage is usually unnecessary 1, 2
- Recommended oral agents include penicillin, amoxicillin, amoxicillin-clavulanate, dicloxacillin, cephalexin, or clindamycin 1
- The majority of cellulitis cases are caused by β-hemolytic streptococci and methicillin-sensitive Staphylococcus aureus when organisms are identified 2, 3
Treatment Duration
- Treat for exactly 5 days if clinical improvement occurs, with extension only if symptoms have not improved within this timeframe 1, 4
- Traditional 7-14 day courses are no longer necessary for uncomplicated cases 1
- Patients should show improvement within 24-48 hours of appropriate antibiotic therapy 4
When to Add MRSA Coverage
Add MRSA-active antibiotics ONLY when specific risk factors are present:
- Penetrating trauma to the ear 1, 4
- Purulent drainage or exudate 1, 4
- Evidence of MRSA infection elsewhere or nasal MRSA colonization 1, 4
- Injection drug use 1
- Systemic inflammatory response syndrome (SIRS) 1
MRSA-Active Regimens (When Indicated)
- Clindamycin 300-450 mg orally every 6 hours provides single-agent coverage for both streptococci and MRSA, avoiding the need for combination therapy 1, 4
- Alternative: Trimethoprim-sulfamethoxazole plus a beta-lactam, or doxycycline plus a beta-lactam 1
- Never use doxycycline or trimethoprim-sulfamethoxazole as monotherapy for typical cellulitis, as their activity against beta-hemolytic streptococci is unreliable 1
Penicillin Allergy Considerations
- For penicillin-allergic patients with typical cellulitis, use clindamycin or erythromycin 4
- Clindamycin is preferred as it covers both streptococci and MRSA 1, 4
Severe Infections Requiring Hospitalization
Hospitalize if any of the following are present:
- Systemic inflammatory response syndrome (SIRS): fever >38°C, tachycardia >90 bpm, tachypnea >24 rpm 1
- Altered mental status or hemodynamic instability 4
- Concern for deeper infection or necrotizing fasciitis 4
- Severe immunocompromise or neutropenia 1
- Failed outpatient treatment 4
Inpatient IV Antibiotic Regimens
- Vancomycin 15-20 mg/kg IV every 8-12 hours is first-line for hospitalized patients with complicated cellulitis (A-I evidence) 1
- Alternative IV agents include linezolid 600 mg IV twice daily, daptomycin 4 mg/kg IV once daily, or clindamycin 600 mg IV three times daily if local resistance is low 1
- For severe cellulitis with systemic toxicity or suspected necrotizing fasciitis, use vancomycin plus piperacillin-tazobactam 3.375-4.5 g IV every 6 hours 1
Adjunctive Measures
- Elevation of the affected area promotes gravity drainage of edema and hastens improvement 1, 4
- Consider systemic corticosteroids (prednisone 40 mg daily for 7 days) in non-diabetic adults, though evidence is limited 1, 4
- Treat predisposing conditions such as edema, eczema, and chronic skin conditions 1
Critical Pitfalls to Avoid
- Do not routinely add MRSA coverage for typical nonpurulent cellulitis without specific risk factors—this represents overtreatment and increases antibiotic resistance 1
- Do not use combination therapy (SMX-TMP plus cephalexin) for pure cellulitis without abscess, ulcer, or purulent drainage, as it provides no additional benefit 1
- Do not continue ineffective antibiotics beyond 48 hours—progression despite appropriate therapy indicates either resistant organisms or a deeper/different infection 1
- If no improvement within 72 hours, consider changing antibiotics, imaging to rule out abscess formation, or hospital admission for IV antibiotics 4
Special Considerations for Ear Cellulitis
While the general principles above apply, ear cellulitis warrants particular attention to:
- Rule out perichondritis (infection of the cartilage), which requires more aggressive treatment and may need antipseudomonal coverage if suspected
- Assess for associated otitis externa or media that may require additional management
- Monitor closely for progression given the proximity to critical structures